Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1611105 10.3389/fphar.2025.1611105 Pharmacology Correction Corrigendum: Neuroprotective effects of a novel peptide through the Rho-integrin-Tie2 and PI3K/Akt pathways in experimental autoimmune encephalomyelitis model Zhou et al. 10.3389/fphar.2025.1611105 Zhou Wen 1 Qu Han 2 Fu Xiao-Xiao 3 Xu Miao-Miao 4 Li Qiang 1 * Jiang Yuan 5 * Han Shu 2 * 1 Department of Emergency Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China 2 Institute of Anatomy and Cell Biology, Medical College, Zhejiang University, Hangzhou, China 3 Institute of Human Anatomy, Histology and Embryology, Basic Medical College, Zhejiang Chinese Medical University, Hangzhou, China 4 Department of Rehabilitation in Traditional Chinese Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China 5 Department of Pulmonology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China

Edited and reviewed by: C. James Chou, Medical University of South Carolina, United States

 *Correspondence: Yuan Jiang, yuanj212@zju.edu.cn; Qiang Li, zjuliqiang@hotmail.com, zjuliqiang@zju.edu.cn; Shu Han, han00shu@zju.edu.cn 10 06 2025 2025 16 1611105 13 04 2025 29 05 2025 Copyright © 2025 Zhou, Qu, Fu, Xu, Li, Jiang and Han. 2025 Zhou, Qu, Fu, Xu, Li, Jiang and Han

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on: Neuroprotective effects of a novel peptide through the Rho-integrin-Tie2 and PI3K/Akt pathways in experimental autoimmune encephalomyelitis model by Zhou W, Qu H, Fu X-X, Xu M-M, Li Q, Jiang Y and Han S (2024). Front. Pharmacol. 15:1290128. doi: 10.3389/fphar.2024.1290128 C16 EAE Tie2 integrin PI3K/Akt pathways section-at-acceptance Experimental Pharmacology and Drug Discovery

In the published article, there was an error in Supplementary Figure S7 as published. The magnification of Supplementary Figure S7S is different from others. This has been corrected.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.